Back to mobile site

Atossa Genetics (ATOS) PT Raised to $8 at Ascendiant Capital

December 8, 2025 4:46 AM EST Send to a Friend
Ascendiant Capital analyst Edward Woo raised the price target on Atossa Genetics (NASDAQ: ATOS) to $8.00 (from $7.75) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login